>
Fa   |   Ar   |   En
   melanocortin 1 receptor (mc1r) polymorphisms’ influence on size and dermoscopic features of nevi  
   
نویسنده vallone m.g. ,tell-marti g. ,potrony m. ,rebollo-morell a. ,badenas c. ,puig-butille j.a. ,gimenez-xavier p. ,carrera c. ,malvehy j. ,puig s.
منبع pigment cell and melanoma research - 2018 - دوره : 31 - شماره : 1 - صفحه:39 -50
چکیده    The melanocortin 1 receptor (mc1r) is a highly polymorphic gene. the loss-of-function mc1r variants (“r”) have been strongly associated with red hair color phenotype and an increased melanoma risk. we sequenced the mc1r gene in 175 healthy individuals to assess the influence of mc1r on nevus phenotype. we identified that mc1r variant carriers had larger nevi both on the back [p-value =.016, adjusted for multiple parameters (adj. p-value)] and on the upper limbs (adj. p-value =.007). specifically, we identified a positive association between the “r” mc1r variants and visible vessels in nevi [p-value =.033, corrected using the fdr method for multiple comparisons (corrected p-value)], dots and globules in nevi (corrected p-value =.033), nevi with eccentric hyperpigmentation (corrected p-value =.033), a high degree of freckling (adj. p-value =.019), and an associative trend with presence of blue nevi (corrected p-value =.120). in conclusion, the mc1r gene appears to influence the nevus phenotype.
کلیدواژه blue nevi ,dermoscopy ,melanocortin 1 receptor (mc1r) gene ,nevogenesis ,nevus
آدرس idibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, dermatology department, melanoma unit, spain. hospital alemán, dermatology department, argentina, idibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, dermatology department, melanoma unit, spain. instituto de salud carlos iii, centro de investigación biomédica en red de enfermedades raras (ciberer), spain, dibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, dermatology department, melanoma unit, spain, idibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, dermatology department, melanoma unit, spain, instituto de salud carlos iii, centro de investigación biomédica en red de enfermedades raras (ciberer), spain. idibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, spain, instituto de salud carlos iii, centro de investigación biomédica en red de enfermedades raras (ciberer), spain. idibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, spain, idibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, dermatology department, melanoma unit, spain. instituto de salud carlos iii, centro de investigación biomédica en red de enfermedades raras (ciberer), spain, idibaps (institut d'investigacions biomèdiques august pi i sunyer), dermatology department, melanoma unit, spain. instituto de salud carlos iii, centro de investigación biomédica en red de enfermedades raras (ciberer), spain, idibaps (institut d'investigacions biomèdiques august pi i sunyer), dermatology department, melanoma unit, spain. instituto de salud carlos iii, centro de investigación biomédica en red de enfermedades raras (ciberer), spain. universitat de barcelona, medicine department, spain, idibaps (institut d'investigacions biomèdiques august pi i sunyer), hospital clínic, dermatology department, melanoma unit, spain. instituto de salud carlos iii, centro de investigación biomédica en red de enfermedades raras (ciberer), spain. universitat de barcelona, medicine department, spain
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved